Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Shokuhin Eiseigaku Zasshi ; 57(5): 166-168, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27784868

RESUMEN

Cefsulodin-irgasan-novobiocin agar (CIN) has been used as a selective agar to detect Yersinia in food or human patients; however, its components can inhibit the growth of some strains of Yersinia enterocolitica serovar O3 and Y. pseudotuberculosis. Recently, a new Yersinia selective agar, CHROMagar Yersinia enterocolitica (CAYe), was developed and evaluated as a novel selective agar for pathogenic Y. enterocolitica. In this research, a total of 251Yersinia strains (176 pathogenic Y. enterocolitica, 59 Y. pseudotuberculosis, and 16 non-pathogenic Yersinia) were cultured on both CIN and CAYe for comparison. Except for 10 of 104 pathogenic Y. enterocolitica O3 strains and 59 Y. pseudotuberculosis strains, 198 Yersinia isolates grew on both media after 48 hr of incubation at 32℃. Of the 10 pathogenic Y. enterocolitica O3 which could not grow on CIN or CAYe, 9 strains could not grow on CIN with supplements and 1 strain could not grow CAYe with supplements. Of 9 strains which did not grow on CIN with supplements, 3 strains could not grow on CIN without supplements. However, 1 strain which did not grow on CAYe with supplements could grow on CAYe without supplements. All of the Y. pseudotuberculosis strains could grow on CIN with/without supplements and on CAYe without supplements. The results indicate that the inhibition of the growth of Y. enterocolitica O3 on CIN is related to the components of CIN; however, the inhibition on CAYe appears to be related to the supplements in CAYe. Therefore, CAYe may be a more useful selective medium than CIN for pathogenic Y. enterocolitica .


Asunto(s)
Medios de Cultivo , Yersinia/efectos de los fármacos , Yersinia/aislamiento & purificación , Agar , Carbanilidas , Cefsulodina , Medios de Cultivo/química , Medios de Cultivo/farmacología , Farmacorresistencia Bacteriana , Humanos , Novobiocina , Temperatura , Factores de Tiempo , Yersinia/clasificación , Yersinia/crecimiento & desarrollo
2.
Heart Vessels ; 20(2): 50-5, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15772778

RESUMEN

We studied the anatomical structure of the isthmus between the inferior vena cava and tricuspid annulus in humans with a three-dimensional electroanatomical mapping system (CARTO, Biosense, Haifa, Israel). Fifteen patients with atrial flutter were studied. Thirteen patients had underlying heart disease. We investigated the anatomical structure of the isthmus with cross sections made from the three-dimensional right atrial map. The cross sections of the isthmus showed a concave shape in 7 patients (47%: group A), convex shape in 2 (13%: group B), and complex shape in 6 (40%: group C). The distance between the IVC and TA was 34+/-17 mm (group A), 25+/-2 mm (group B), 34+/-16 mm (group C), and 32+/-15 mm (Total), respectively. The distance between the top and bottom was 6+/-5 mm (group A), 3 mm (group B), 6+/-3 mm (group C), and 6+/-4 mm (total), respectively. Seven of 15 patients exhibited an uneven surface of more than 5 mm in depth and 4 of 15 patients had one of more than 10 mm. The anatomical structure of the isthmus varies. To carry out precise catheter ablation, these variations should be taken into consideration to ensure an effective procedure.


Asunto(s)
Aleteo Atrial/patología , Técnicas Electrofisiológicas Cardíacas , Imagenología Tridimensional , Magnetismo , Válvula Tricúspide/patología , Vena Cava Inferior/patología , Adulto , Aleteo Atrial/fisiopatología , Aleteo Atrial/cirugía , Ablación por Catéter , Femenino , Humanos , Interpretación de Imagen Asistida por Computador , Masculino , Persona de Mediana Edad , Cirugía Asistida por Computador , Válvula Tricúspide/fisiopatología , Vena Cava Inferior/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA